The transparency provisions of the No Surprises Act require group health plans and health insurance issuers to report information on prescription drugs and health care spending to the Departments of Labor, Health and Human Services and the Treasury (Departments). This reporting process is referred to as the “prescription drug data collection” (or “RxDC report”), and it must be submitted by Dec. 27, 2022.

Submission Grace Period

On Dec. 23, 2022, the Departments released an FAQ stating that, for the 2020and 2021 data submissions due by Dec. 27, 2022, they will not take enforcement action with respect to any plan or issuer that uses a good faith, reasonable interpretation of the regulations and the RxDC reporting instructions in making its submission.

The Departments are also providing a submission grace period through Jan.31, 2023, and will not consider a plan or issuer to be out of compliance with these requirements provided that a good faith submission of 2020 and 2021data is made on or before that date. In addition, to facilitate the submission process, the Departments are providing clarifications and flexibilities with respect to reporting requirements for this data(e.g., allowing multiple submissions by the same reporting entity, email submission of certain data for certain plans and optional reporting for certain data), which are outlined in the FAQ.

Employer Compliance Steps

Most employers will rely on their carriers, TPAs or other third parties to report prescription drug costs by the deadline. Employers should update their written agreements with these parties to reflect that responsibility and confirm they will timely submit the reports.

For a copy of this notice, click here: Submission Grace Period Issued for Prescription Drug Reporting

Leave a comment

Skip to content